Delivery Order SPE2DB20D3103-SPE2DB23FP5W0

Award Date 8/31/23
Potential Completion Date 9/1/23
Potential Value $16K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Xulane 150-35 mcg/day patch. The contract has a ceiling value of $3,049.48 and a completion date of January 11, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Xulane 150-35 mcg/day patch. The contract, valued at $4,440.37, is a firm fixed-price delivery order with a completion date of February 23, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Xulane 150-35 mcg/day Patch 3s, a prescription contraceptive patch. The contract has a ceiling value of $2,033.04 and a completion date of March 2, 2023. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The $1,612.53 firm fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive patch, with a period of performance through January 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,355.75 firm fixed-price delivery order is for the pharmaceutical product Xulane 150-35 mcg/day patch, a contraceptive medication. The contract has an ultimate completion date of May 22, 2023 and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a transdermal contraceptive patch. The contract has a ceiling value of $1,453.29 and is a firm-fixed-price delivery order contract, with a period of performance through June 6, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,641.93, is for the delivery of Xulane 150-35 mcg/day patch 3s, a pharmaceutical product. This is a firm-fixed-price delivery order contract with a completion date of February 15, 2024. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a prescription contraceptive product. The firm-fixed-price delivery order, valued at $3,420.86, has an ultimate completion date of August 2, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,922.69 firm fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive medication. The contract has an ultimate completion date of December 14, 2022 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This federal contract award, valued at $2,854.52, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order for XULANE 150-35 MCG/DAY PATCH 3S, a medical product, with a completion date of December 6, 2023. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp,...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FP5W0
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Xulane 150-35 mcg/day patch. The contract is a firm fixed-price delivery order with a ceiling value of $16,361.86 and a completion date of September 1, 2023.

The contract is not designated with a set-aside. AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through December 2025. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 2/27/25, 10:41 AM